Spectral Diagnostics (US) Inc. – Endotoxemia

Access Program Information

Open-label, non-controlled study of standard care plus the TORAYMYXIN PMX-20R (PMX
cartridge) in subjects who have endotoxemia and septic shock. This is a continued access
study subsequent to the EUPHRATES clinical trial NCT01046669.

Rare Disease: